Tower Research Capital (TRC)’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $237K | Buy |
5,425
+2,858
| +111% | +$125K | 0.01% | 1623 |
|
|
2025
Q1 | $70.3K | Sell |
2,567
-2,245
| -47% | -$61.4K | ﹤0.01% | 1984 |
|
|
2024
Q4 | $194K | Buy |
4,812
+2,350
| +95% | +$94.5K | ﹤0.01% | 1747 |
|
|
2024
Q3 | $117K | Sell |
2,462
-10,663
| -81% | -$505K | ﹤0.01% | 2112 |
|
|
2024
Q2 | $392K | Buy |
13,125
+12,421
| +1,764% | +$371K | 0.01% | 1534 |
|
|
2024
Q1 | $28.3K | Sell |
704
-2,049
| -74% | -$82.4K | ﹤0.01% | 2700 |
|
|
2023
Q4 | $70.1K | Sell |
2,753
-3,899
| -59% | -$99.3K | ﹤0.01% | 2911 |
|
|
2023
Q3 | $92.5K | Buy |
6,652
+3,753
| +129% | +$52.2K | ﹤0.01% | 2039 |
|
|
2023
Q2 | $66.6K | Buy |
2,899
+1,146
| +65% | +$26.3K | ﹤0.01% | 2323 |
|
|
2023
Q1 | $52K | Sell |
1,753
-3,646
| -68% | -$108K | ﹤0.01% | 2455 |
|
|
2022
Q4 | $135K | Sell |
5,399
-13,223
| -71% | -$331K | 0.01% | 1593 |
|
|
2022
Q3 | $405K | Buy |
18,622
+7,093
| +62% | +$154K | 0.01% | 1304 |
|
|
2022
Q2 | $227K | Buy |
11,529
+8,363
| +264% | +$165K | 0.01% | 1671 |
|
|
2022
Q1 | $134K | Sell |
3,166
-1,450
| -31% | -$61.4K | ﹤0.01% | 2006 |
|
|
2021
Q4 | $293K | Buy |
4,616
+910
| +25% | +$57.8K | 0.01% | 1492 |
|
|
2021
Q3 | $218K | Buy |
3,706
+1,986
| +115% | +$117K | 0.01% | 1738 |
|
|
2021
Q2 | $83K | Buy |
1,720
+236
| +16% | +$11.4K | ﹤0.01% | 2574 |
|
|
2021
Q1 | $58K | Buy |
1,484
+734
| +98% | +$28.7K | ﹤0.01% | 2994 |
|
|
2020
Q4 | $47K | Sell |
750
-220
| -23% | -$13.8K | ﹤0.01% | 3182 |
|
|
2020
Q3 | $31K | Buy |
+970
| New | +$31K | ﹤0.01% | 3715 |
|